Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Article Category: Research Article

Published Online: Feb 21, 2018

Page range: 281 - 288

Received: Nov 22, 2017

Accepted: Nov 30, 2017

DOI: https://doi.org/10.2478/raon-2018-0009

Keywords

locally advanced NSCLC, survival, immunotherapy, PD-L1 expression, chemoradiotherapy

© 2018 Martina Vrankar, Karmen Stanic, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.